Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7X6K

SARS-CoV-2 3CL protease (3CLpro) in complex with compound 3w

Summary for 7X6K
Entry DOI10.2210/pdb7x6k/pdb
Descriptor3C-like proteinase, 1H-indole-2-carbaldehyde (3 entities in total)
Functional Keywordsviral protein-inhibitor complex, viral protein/inhibitor
Biological sourceSevere acute respiratory syndrome coronavirus 2
Total number of polymer chains1
Total formula weight33970.71
Authors
Su, H.,Nie, T.,Xie, H.,Li, Z.W.,Li, M.J.,Xu, Y. (deposition date: 2022-03-07, release date: 2022-07-06, Last modification date: 2023-11-29)
Primary citationPillaiyar, T.,Flury, P.,Kruger, N.,Su, H.,Schakel, L.,Barbosa Da Silva, E.,Eppler, O.,Kronenberger, T.,Nie, T.,Luedtke, S.,Rocha, C.,Sylvester, K.,Petry, M.R.I.,McKerrow, J.H.,Poso, A.,Pohlmann, S.,Gutschow, M.,O'Donoghue, A.J.,Xu, Y.,Muller, C.E.,Laufer, S.A.
Small-Molecule Thioesters as SARS-CoV-2 Main Protease Inhibitors: Enzyme Inhibition, Structure-Activity Relationships, Antiviral Activity, and X-ray Structure Determination.
J.Med.Chem., 65:9376-9395, 2022
Cited by
PubMed Abstract: The main protease (M, 3CL) of SARS-CoV-2 is an attractive target in coronaviruses because of its crucial involvement in viral replication and transcription. Here, we report on the design, synthesis, and structure-activity relationships of novel small-molecule thioesters as SARS-CoV-2 M inhibitors. Compounds and exhibited excellent SARS-CoV-2 M inhibition with / of 58,700 M s ( = 0.0141 μM) and 27,200 M s ( = 0.0332 μM), respectively. In Calu-3 and Vero76 cells, compounds , , , , , and displayed antiviral activity in the nanomolar range without host cell toxicity. Co-crystallization of and with SARS-CoV-2 M was accomplished, and the X-ray structures showed covalent binding with the catalytic Cys145 residue of the protease. The potent SARS-CoV-2 Mpro inhibitors also inhibited the M of other beta-coronaviruses, including SARS-CoV-1 and MERS-CoV, indicating that they might be useful to treat a broader range of coronaviral infections.
PubMed: 35709506
DOI: 10.1021/acs.jmedchem.2c00636
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.34 Å)
Structure validation

230744

PDB entries from 2025-01-29

PDB statisticsPDBj update infoContact PDBjnumon